EXPE
72
8
MRK
45
4
KLAC
59
3
SWK
78
7
APD
44
4
HSY
40
2
ADI
61
4
NFLX
59
2
HRL
36
4
SYF
64
4
PX
52
2
MDLZ
73
2
GE
82
5
GM
55
3
CMI
55
4
SLB
44
2
HPE
46
2
MCK
52
6
SJM
34
6
FITB
58
5
EXPE
72
8
MRK
45
4
KLAC
59
3
SWK
78
7
APD
44
4
HSY
40
2
ADI
61
4
NFLX
59
2
HRL
36
4
SYF
64
4
PX
52
2
MDLZ
73
2
GE
82
5
GM
55
3
CMI
55
4
SLB
44
2
HPE
46
2
MCK
52
6
SJM
34
6
FITB
58
5
Financhill
Back

C4 Therapeutics Stock Predictions

How this hedge fund manager trades weekly options

Claim your free training on trading weekly options
Sell
24

CCCC
C4 Therapeutics

Last Price:
6.31
Seasonality Move:
-34.49%

7 Day Trial

ALL ACCESS PASS

$ 7

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

C4 Therapeutics Stock Forecast

  • Over the next 52 weeks, C4 Therapeutics has on average historically fallen by 2.5% based on the past 3 years of stock performance.
  • C4 Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is C4 Therapeutics Stock Undervalued?
    The current C4 Therapeutics [CCCC] share price is $6.44. The Score for CCCC is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • CCCC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will C4 Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, C4 Therapeutics has on average historically fallen by 2.5% based on the past 3 years of stock performance.

C4 Therapeutics Stock Rating

Sell
24
C4 Therapeutics (CCCC) is a Sell

Is C4 Therapeutics overpriced?

  • C4 Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

C4 Therapeutics Stock Price History

Is CCCC stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CCCC is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
c4therapeutics.com

52-Week Data

52-Week High:
11.88
52-Week Low:
1.06

Prediction Charts

Market Cap:
446.54M
Price in USD:
6.44
Volume:
3.33M
Beta:
3.07

Technical Analysis

SMA50:
6.05
SMA100:
5.74
SMA200:
6.21
52-Wk Change:
178.79%

Stock Predictions

  • Is C4 Therapeutics stock public?
    Yes, C4 Therapeutics is a publicly traded company.
  • What is the C4 Therapeutics stock quote today?
    The C4 Therapeutics stock price is 6.44 USD today.
  • How to buy C4 Therapeutics stock online?
    You can buy C4 Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-26 6.73 6.93 7.08 6.58
Aug-27 6.81 6.43 6.94 6.27
Aug-28 6.37 6.37 6.44 6.15
Aug-29 6.39 6.43 6.71 6.32
Aug-30 6.42 6.32 6.53 6.07
Sep-3 6.31 6.01 6.31 5.68
Sep-4 5.96 5.87 6.28 5.83
Sep-5 5.90 5.83 6.04 5.66
Sep-6 5.88 5.40 6.04 5.28
Sep-9 4.56 5.73 5.73 4.56
Sep-10 5.73 6.52 6.70 5.66
Sep-11 6.49 6.00 6.51 5.81
Sep-12 6.06 6.41 6.41 5.98
Sep-13 6.53 6.44 7.22 5.70

C4 Therapeutics Earnings

C4 Therapeutics Earnings Report: Per Share C4 Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

C4 Therapeutics Forecast Revenue Growth

C4 Therapeutics Stock Analysis: Historical quarterly revenues per share for C4 Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.03 per share, an increase this year of $1.53 per share, and a decrease next year of $0.31 per share.

* C4 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.